Ayala Pharmaceuticals, Inc.
ADXSDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001100397
Ayala Pharmaceuticals, Inc. was delisted in 2025; its insiders filed their last Form 4 on Mar 6, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in Ayala Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 0
- −1 vs. Q1 2025
- Shares held
- 0
- −3 (−100.0%) vs. Q1 2025
- Total value
- $0
- $0 vs. Q1 2025
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 1 | $1 |
| Q1 2024 | 1 | $2 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 1 | $46.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Ayala Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vermillion & White Wealth Management Group, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |